Search - tctmd.com

Displaying 61 - 80 of 126

Sort: Relevancy | Date

Presentation THT 2024

Innovations in Management of ECMO-Supported Patients

Presenter: E Wilson Grandin

March 05, 2024

Presentation THT 2024

Estimating the Effect of Mechanical Circulatory Support on Mortality, Complications, and Readmission Rates in Patients Admitted with ST-Elevation Myocardial Infarction with Cardiogenic Shock who underwent Percutaneous Coronary Intervention

Presenter: Debapria Das

March 05, 2024

Presentation THT 2024

Innovations for RV Support in Shock

Presenter: Jaime Hernandez Montfort

March 05, 2024

Presentation THT 2024

Initial Experience of ECMO and E-CPR in Cardiogenic Shock in a Tertiary Center in Mexico

Presenter: José Alfredo Salinas-Casanova

March 05, 2024

Presentation THT 2024

Early Experience With the Magenta Elevate™ Micro-Axial Flow Pump

Presenter: Ehud Schwammenthal

March 05, 2024

Presentation THT 2024

Early Experience With the Supira Microaxial Flow Pump

Presenter: Azeem Latib

March 05, 2024

Presentation THT 2024

The Impella Portfolio of Devices for Cardiogenic Shock (Left-Sided Support)

Presenter: Justin Fried

March 05, 2024

Presentation THT 2024

Istraoxime for Cardiogenic Shock

Presenter: Gad Cotter

March 05, 2024

Presentation THT 2024

Potential Benefits of Decreasing HR: Adjuntive Therapies to Pumps

Presenter: Hidetaka Morita

March 05, 2024

Presentation THT 2024

Cardiogenic Shock: The Urgent Need for Innovation in Devices and Technologies for Shock

Presenter: Navin K. Kapur

March 05, 2024

Presentation THT 2024

Clinical Outcomes and Adverse Events in Cardiogenic Shock Patients who Recieved Impella 5.0/5.5: A Report from the Cardiogenic Shock Working Group

Presenter: Justin Fried

March 05, 2024

Presentation THT 2024

Cardiogenic Shock in Stress Induced Cardiomyopathy Complicated by Left Ventricular Outflow Obstruction: Hemodynamic-Tailored Management

Presenter: Mary Quien

March 05, 2024

Presentation THT 2024

Cardiogenic Shock: The Case for Feasibility and Recovery

Presenter: Aasim Afzal

March 04, 2024

Presentation THT 2024

Achieving Heart Recovery in HF with Cardiogenic Shock

Presenter: Debbie Rinde-Hoffman

March 04, 2024

Presentation THT 2024

Early Feasibility Study of the Vivasure PerQseal® Closure Device System After Use of the Impella Device for Cardiogenic Shock or Protected Percutaneous Coronary Intervention

Presenter: Rajiv Tayal

March 04, 2024

$Refractory Cardiogenic Shock With Severe LV Dysfunction and a Mechanical Complication of Inferior Wall MI$

Presentation THT 2023

Refractory Cardiogenic Shock With Severe LV Dysfunction and a Mechanical Complication of Inferior Wall MI

Presenter: Nazli Okumus

March 22, 2023

Presentation THT 2023

Safety and Efficacy of Istaroxime 1.0 and 1.5 µg/kg/min for Patients With Pre Cardiogenic Shock

Presenter: Gad Cotter

March 22, 2023

Presentation THT 2023

Does Obesity Paradox Exist in Cardiogenic Shock?

Presenter: Maya Guglin

March 22, 2023

Presentation THT 2023

Pulmonary Artery Catheter Use in Patients with Heart Failure Cardiogenic Shock (HF-CS): An Analysis from the Cardiogenic Shock Working Group (CSWG)

Presenter: Adnan Khalif

March 21, 2023

Presentation THT 2023

Acute MR With MCS/TEER

Presenter: Thomas Waggoner

March 21, 2023

Advertisement

Innovations in Management of ECMO-Supported Patients

Estimating the Effect of Mechanical Circulatory Support on Mortality, Complications, and Readmission Rates in Patients Admitted with ST-Elevation Myocardial Infarction with Cardiogenic Shock who underwent Percutaneous Coronary Intervention

Innovations for RV Support in Shock

Initial Experience of ECMO and E-CPR in Cardiogenic Shock in a Tertiary Center in Mexico

Early Experience With the Magenta Elevate™ Micro-Axial Flow Pump

Early Experience With the Supira Microaxial Flow Pump

The Impella Portfolio of Devices for Cardiogenic Shock (Left-Sided Support)

Istraoxime for Cardiogenic Shock

Potential Benefits of Decreasing HR: Adjuntive Therapies to Pumps

Cardiogenic Shock: The Urgent Need for Innovation in Devices and Technologies for Shock

Clinical Outcomes and Adverse Events in Cardiogenic Shock Patients who Recieved Impella 5.0/5.5: A Report from the Cardiogenic Shock Working Group

Cardiogenic Shock in Stress Induced Cardiomyopathy Complicated by Left Ventricular Outflow Obstruction: Hemodynamic-Tailored Management

Cardiogenic Shock: The Case for Feasibility and Recovery

Achieving Heart Recovery in HF with Cardiogenic Shock

Early Feasibility Study of the Vivasure PerQseal® Closure Device System After Use of the Impella Device for Cardiogenic Shock or Protected Percutaneous Coronary Intervention

Refractory Cardiogenic Shock With Severe LV Dysfunction and a Mechanical Complication of Inferior Wall MI

Safety and Efficacy of Istaroxime 1.0 and 1.5 µg/kg/min for Patients With Pre Cardiogenic Shock

Does Obesity Paradox Exist in Cardiogenic Shock?

Pulmonary Artery Catheter Use in Patients with Heart Failure Cardiogenic Shock (HF-CS): An Analysis from the Cardiogenic Shock Working Group (CSWG)

Acute MR With MCS/TEER

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content